Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.

F. Stocchi, S. Ruggieri, A. Antonini, F. Baronti, G. Brughitta, P. Bellantuono, D. Bravi, A. Agnoli

Research output: Contribution to journalArticle

Abstract

The continuous dopaminergic stimulation provided by infusion of dopamine agonist drugs, is a very effective strategy to control ON-OFF fluctuation in Parkinson's disease. Lisuride is a potent dopamine agonist drug, very soluble in water and can be administered subcutaneously. Many authors have shown that the subcutaneous infusion of lisuride can control fluctuations when applied in combination with oral levodopa as a 24 hour continuous infusion regimen. In this study, lisuride was given without any other antiparkinsonian medicament and using a 12 hour infusion regimen wherever possible. 13 fluctuating Parkinsonian patients were studied. 6 out of these 13 were satisfactory treated with lisuride alone and the remaining 7 with a combination of Lisuride + oral levodopa. Only in 3 out of 13 patients the 24 hour infusion regimen was required.

Original languageEnglish
Pages (from-to)27-33
Number of pages7
JournalJournal of Neural Transmission, Supplement
Volume27
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.'. Together they form a unique fingerprint.

  • Cite this

    Stocchi, F., Ruggieri, S., Antonini, A., Baronti, F., Brughitta, G., Bellantuono, P., Bravi, D., & Agnoli, A. (1988). Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration. Journal of Neural Transmission, Supplement, 27, 27-33.